SEC Form 4 · accession 0000899243-17-019349
CytoDyn Inc. · CYDY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Carl Dockery
Director
Period of report
Jul 28, 2017
Accepted (ET)
Jul 31, 2017 · 5:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001175680
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Convertible Promissory NoteF3,F4,F1,F2 | $0.75 | Jul 28, 2017 | A | 50,000 | A | Jul 28, 2017 | Jan 31, 2018 | Common Stock | 66,666 | 50,000 | I |
| WarrantsF3,F4,F1 | $1.00 | Jul 28, 2017 | A | 33,333 | A | Jul 28, 2017 | Jul 28, 2022 | Common Stock | 33,333 | 33,333 | I |
Explanation of responses
- F1Subject to adjustment in the event of certain stock split or reverse stock split recapitalizations.
- F2Does not include additional shares issuable upon conversion of accrued interest.
- F3As part of a private offering to accredited investors, Alpha Venture Capital Partners, LP ("AVCP") purchased from the issuer for a combined price of $50,000 (i) a $50,000 convertible promissory note, bearing interest at 7.0% annually, which is convertible into shares of the issuer's common stock at an initial conversion price of $0.75 per share, and (ii) a warrant covering 50% of the number of shares underlying the convertible promissory note, at an exercise price of $1.00 per share.
- F4The reporting person is the sole member of Alpha Advisors, LLC, the investment advisor for AVCP, and the managing member of Alpha Venture Capital Management, LLC, the general partner of AVCP. The reporting person disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest in such securities.